Share chart SAB Biotherapeutics, Inc.
Extended chart
Simple chart
About SAB Biotherapeutics, Inc.
SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies based on human antibodies. It has applied advanced genetic engineering and antibody science to develop transchromosomic bovine herds that produce fully human antibodies targeted at infectious diseases and immune and autoimmune disorders, including infectious diseases, influenza, CDI, type 1 diabetes, organ transplantation, and oncology, as well as immunology, gastroenterology, and respiratory diseases. more detailsIPO date | 2021-02-09 |
---|---|
ISIN | US78397T1034 |
Industry | Biotechnology |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Сайт | https://www.sabbiotherapeutics.com |
Цена ао | 1.63 |
Change price per day: | -1.23% (1.63) |
---|---|
Change price per week: | -0.6173% (1.62) |
Change price per month: | -5.85% (1.71) |
Change price per 3 month: | -60.54% (4.08) |
Change price per half year: | -40.37% (2.7) |
Change price per year: | -70.83% (5.52) |
Change price per 3 year: | -24.77% (2.14) |
Change price per year to date: | -58.72% (3.9) |
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
Institutions | Volume | Share, % |
---|---|---|
Marshall Wace LLP | 4585282 | 49.7 |
RA Capital Management, L.P. | 2374081 | 25.73 |
COMMODORE CAPITAL LP | 1831746 | 19.86 |
RTW Investments LP | 917828 | 9.95 |
BVF Inc. | 917828 | 9.95 |
Sessa Capital IM, L.P. | 458457 | 4.97 |
Vanguard Group Inc | 99614 | 1.08 |
First Premier Bank | 80754 | 0.88 |
Pathstone Holdings, LLC | 50651 | 0.55 |
Geode Capital Management, LLC | 35636 | 0.39 |
ETF | Share, % | Profitability for 1 year, % | Dividends, % |
---|---|---|---|
iShares Micro-Cap ETF | 0.00541 | 17.09 | 1.54048 |
Head | Job title | Payment | Year of birth |
---|---|---|---|
Mr. Samuel J. Reich | CEO & Executive Chairman | 363.2k | 1975 (50 years) |
Dr. Eddie Joe Sullivan Ph.D. | Co-Founder, President & Director | 402.56k | 1966 (59 years) |
Ms. Christine E. Hamilton M.B.A. | Co-Founder & Independent Director | 25k | 1956 (69 years) |
Dr. Alexandra Kropotova M.B.A., M.D. | Executive VP & Chief Medical Officer | 774.45k | 1973 (52 years) |
Dr. Edward D. Hamilton D.V.M. | Co-Founder & Board Observer | N/A | |
Dr. Christoph Bausch M.B.A., Ph.D. | Executive VP & COO | 443.2k | 1971 (54 years) |
Dr. Carlos N. Carillo Ph.D. | Senior Vice President of Regulatory Affairs | N/A | |
Mr. Mark W. Conley | Interim Chief Financial Officer |
Address: United States, Sioux Falls. SD, 2100 East 54th Street North - open in Google maps, open in Yandex maps
Website: https://www.sabbiotherapeutics.com
Website: https://www.sabbiotherapeutics.com